Navigation Links
FASEB SRC announces conference: Matricellular Proteins in Development, Health, and Disease
Date:2/4/2013

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): Matricellular Proteins in Development, Health, and Disease.

Interactions between cells and their surrounding extracellular matrix (ECM) are the basis for multi-cellular life and essential for cell and tissue organization in all metazoan organisms. Structural ECM components such as collagens, fibronectin, and laminins, are secreted by cells and assembled extracellularly into organized sheets (basement membranes) or three-dimensional fibrils and networks (connective tissue matrix). ECM also contains less abundant, but highly regulated, components that play important roles in controlling cell behavior and matrix remodeling. Because of their distinctive localizations and functional attributes in the ECM, these proteins have been termed matricellular proteins and include members of the thrombospondin, CCN, tenascin, osteopontin, periostin, fibulin, and SPARC families.

The purpose of this conference is to focus on these matricellular proteins and to examine their structure-function relationships and their impact on signaling networks that play key roles in disease, homeostasis, repair, and development. The conference format includes lectures and poster sessions and short talks selected from submitted abstracts and late breaking work. The program covers both mechanistic scientific perspectives (Sessions 1-3) and disease specific emphases (Sessions 4-9). Mechanistic sessions will discuss novel regulatory mechanisms of the matricellular proteins and their receptors (Session 1) and the complex roles of matricellular proteins in regulation of multiple growth factors in disease (Session 3), which is an important function of these proteins in homeostasis and disease.

For the first time, we will have a session to highlight mammalian and non-mammalian model systems (Session 2). The long-standing disease focus areas of the field in cardiovascular disease (Session 6), carcinogenesis/angiogenesis (Session 7), and in musculoskeletal development and disease (Session 9) are well represented on the program. In addition, there will be three sessions focusing on emerging areas of intense activity and significant progress in the matricellular field over the past two-three years: inflammation and immunity (Session 4), diabetes and obesity (Session 5), and neurobiology (synapse formation, neuropathic pain) (Session 8).

Inclusion of women, minorities, and young scientists has been emphasized in developing the program. Invited speakers represent leaders in the basic sciences, clinical investigators who are defining the roles of matricellular proteins in the etiology of inherited disorders and several major diseases of adults, and investigators developing novel therapeutics to treat these diseases. The overall objectives of this meeting are to foster new knowledge in the field of matricellular proteins that will lead to development of therapeutics for the treatment of human diseases, facilitate the development of new multidisciplinary collaborations and research directions, and encourage the development of young scientists in this field.

FASEB SRC has announced a total of 34 SRCs in 2013. To register for an SRC, view preliminary programs, or find a listing of all our 2013 SRCs, please visit www.faseb.org/SRC.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Related biology news :

1. FASEB SRC announces conference registration open for: Biology and Chemistry of Vision
2. FASEB SRC announces conference registration open for: Hematologic Malignancies
3. FASEB SRC announces conference registration open for: Mechanisms in Plant Development Conference
4. FASEB SRC announces conference registration open for: Ciliate Molecular Biology
5. FASEB SRC announces conference: Renal Hemodynamics: Integrating with the Nephron & Beyond
6. FASEB SRC announces: Mechanism and Regulation of Prokaryotic Transcription Conference
7. FASEB SRC announces conference registration open: The Biology of Calpains in Health and Disease
8. FASEB SRC announces conference: Gastrointestinal Tract XV: Epithelia, Microbes, Inflammation & Cancer
9. FASEB urges biomedical research community to speak out against sequestration
10. FASEB lauds Air India for transporting research animals
11. Undergraduate Student Summer Research Award recipients announced for the 2012 FASEB MARC summer research opportunity program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... DIEGO , Jan. 12, 2017  Trovagene, Inc. ... tumor DNA (ctDNA) technologies, today announced that it has ... Europe and the Middle East ... tests.  This milestone marks the first wave of international ... for urine and blood samples. The initial ...
(Date:1/11/2017)... , Jan. 11, 2017  Michael Johnson, co-founder of Visikol ... Capital Group, Inc., has been named to the elite "Forbes 30 ...  was one of 600 people in 20 fields nationwide to be ... of the 15,000 applicants were selected. ... He is currently a PhD candidate at Rutgers ...
(Date:1/4/2017)... , Jan. 4, 2017  For the thousands of attendees at ... global leader in connected health and biometric measurement devices and services, will ... On display in A&D Medical,s special CES Exhibit Suite ... the ongoing expansion of the company,s WellnessConnected product platform.  ... ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... DUBLIN , Jan 19, 2017 Research ... Market by Profiling Technology, Biomolecules, Cancer Type, Application - Global Opportunity ... ... Report, forecasts that the global market is projected to reach $15,737 ... of 13% from 2016 to 2022. Omic technologies ...
(Date:1/19/2017)... and HOUSTON , ... ("NX Prenatal") today announced the formation of its ... leading clinicians and industry veterans who enhance the ... as it accelerates development of its novel prenatal ... provide medical, clinical and strategic guidance for the ...
(Date:1/19/2017)... Jan 19, 2017 Research and Markets ... has announced the addition of the ... - Forecast to 2025" report to their offering. ... The report provides a detailed analysis on current and future market ... 2025, using estimated market values as the base numbers ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... software to leading biopharmaceutical and medical device manufacturers and regulators, is proud to ... CFR Part 11-compliant email client designed to provide product vigilance departments with the ...
Breaking Biology Technology: